COVID-19 is an emerging, rapidly evolving situation.
Global health briefs April 2012
March / April 2012 | Volume 11, Issue 2
NIH and Lilly collaborate to speed drug development
The NIH has announced it will collaborate with Eli Lilly to generate a publicly available resource to profile the effects of thousands of approved and investigational medicines in a variety of sophisticated disease-relevant testing systems. Comprehensive knowledge of the biological profiles of these medicines and molecules may enable biomedical researchers to better predict treatment outcomes, improve drug development, and lead to more specific and effective approaches.
NIH launches clinical trials website
The NIH has launched a new website NIH Clinical Research Trials and You, to help educate the public about clinical trials, why they matter and the benefits of participation.
Fogarty grantees develop free mentors' manual for researchers
Fogarty grantees in Uganda have developed a free mentors' manual for health sciences training in Africa. Drs. Peter Mugyenyi and Nelson Sewankambo co-edited the guide, which addresses various ways to improve mentorship of both undergraduate and postgraduate students.
UW develops global health data catalog
The University of Washington has developed a new resource to improve data discoverability and make it easier to find relevant information about data. Called the Global Health Data Exchange, the catalog contains details of over 7,000 demographic, global public health and health-related data sources.
World Bank releases fiscal study of HIV/AIDS
To help countries develop better national health plans and budgets, the World Bank has produced a study called The fiscal dimension of HIV/AIDS in Botswana, South Africa, Swaziland, and Uganda. The report is intended to help countries transition from emergency crisis financing for AIDS to sustainable development financing with stronger national ownership and responsibility.
To view Adobe PDF files,
download current, free accessible plug-ins from Adobe's website.